HRES 803 119th Congress House Health

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Introduced: October 10, 2025 Introduced by: Rose, John W. Republican · Tennessee See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Agreed to (House)

Oct 10, 2025

Referred to the House Committee on Energy and Commerce.

Oct 10, 2025

Submitted in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now October 10, 2025

Referred to the House Committee on Energy and Commerce.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Energy and Commerce Committee
House of Representatives

Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

SUSAN B ANTHONY LIST
for SUSAN B ANTHONY LIST · Virginia · 4th Quarter (Oct 1 - Dec 31) 2025

Cosponsors 11

Cline, Ben

Virginia · Nov 4, 2025

Guest, Michael

Mississippi · Nov 4, 2025

Harris, Andy

Maryland · Oct 28, 2025

Aderholt, Robert B.

Alabama · Oct 17, 2025

Biggs, Sheri

South Carolina · Oct 10, 2025

Carter, Earl L. "Buddy"

Georgia · Oct 10, 2025

Grothman, Glenn

Wisconsin · Oct 10, 2025

Hageman, Harriet M.

Wyoming · Oct 10, 2025

Harshbarger, Diana

Tennessee · Oct 10, 2025

LaMalfa, Doug

California · Oct 10, 2025

Moore, Barry

Alabama · Oct 10, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). H. Res. 803: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.. 119th Congress. Open America. https://openamerica.io/bill/119-HRES-803/

MLA

"H. Res. 803: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HRES-803/.

Bluebook (legal)

H. Res. 803, 119th Cong. (2026), https://openamerica.io/bill/119-HRES-803/.

Markdown link

[H. Res. 803: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.](https://openamerica.io/bill/119-HRES-803/)